Categories
Pharmaceutical

Asia-Pacific Is Expected To Prove Lucrative For Sinus Implants Market – Fact.MR A

Distinct attributes of sinus implants such as direct delivery of steroid medication to sinus cavity lining minimize or completely erase the need for additional oral corticosteroid medications. The effective delivery of corticosteroid reduced the post-surgery side effects such as discomfort, congestion, and scarring. The sinus implants also improve the success rate of FESS surgery and reduce the probabilities of additional surgery.

Request for Sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=950

Sinus Implants Market: Overview

Growing number of FESS based procedures pave the path for sinus implants market. The enhanced success rate of FESS procedures followed by sinus implants would be the key growth factor for sinus implant market. Favorable reimbursement guides (Category I CPT codes in 2011) for sinus implants are attracting large medical device manufacturers to enter into the market.

Companies such as Medtronic have capability to build drug releasing stents. However, small companies are likely to gain competencies by developing novel product line in the market. However, risk of product liability claims to sinus implant imposes a threat to market growth due associated side effects, manufacturing defects, misuse or abuse of sinus implants products. Such product liability claims lead to costs of litigation, product recall from the market which eventually affects the revenue generation for the manufacturers.

Sinus Implants Market: Segmentation

Tentatively, global Sinus Implants Market has been segmented on the basis of component, end user, and geography.

Based on implant type, global Sinus Implants market is segmented as below:

  • Non-drug-releasing implants
  • Drug-releasing implants

Based on end user, global Sinus Implants market is segmented as below:

  • Hospital
  • ENT Clinics

* Full Segmentation Available on Demand*

Sinus Implants Market: Key Players

Some of the players identified in global Sinus Implants market include Intersect ENT, Inc. In Dec 2017, the company had received FDA approval for its SINUVA Sinus Implant indicated for nasal polyps treatment, in patients (above 18 years) who have undergone ethmoid sinus surgery. The approval was supported by the clinical outcome of 400 patients including RESOLVE II pivotal study.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=950

Sinus Implants Market: Regional Outlook

Geographically, global sinus implants market is segmented into regions viz. North America, Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America & Europe region would witness double digits growth owing to shift in trend of hospital based FESS procedure to physician’s office.

Another reason behind the lucrative growth opportunity of sinus implant market is increasing prevalence of chronic sinusitis which is anticipated to promote the growth of FESS procedure in the North America & European region. Medical tourism in ASEAN countries would be the key success factor for the growth of sinus implant market. The lower cost of FESS surgery over US/EU countries makes Asia region a favorable destination for FESS surgery.

The significant benefits of sinus implant in conjugation with FESS surgery is expected to fuel the market growth. In addition, the growing awareness among otolaryngologists about the use of sinus implant post FESS surgery through various certifications and courses spur the adoption rate of sinus implant globally. However, potential side effects such as premature displacement of implant, swallowing implant associated with sinus implant would hinder the market growth.

The Report Covers Exhaustive Analysis On:

  • Sinus Implants Market Drivers, Segments and Restraints.
  • Sinus Implants Market Survey and Dynamics
  • Sinus Implants Market Size & Demand
  • Sinus Implants Key Trends/Issues/Challenges
  • Sinus Implants Sales, Competition & Companies involved

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com